BACKGROUND: Patient, provider, and systems barriers contribute to delays in cancer care, a lower quality of care, and poorer outcomes in vulnerable populations, including low-income, underinsured, and racial/ethnic minority populations. Patient navigation is emerging as an intervention to address this problem, but navigation requires a clear definition and a rigorous testing of its effectiveness. Pilot programs have provided some evidence of benefit, but have been limited by evaluation of single-site interventions and varying definitions of navigation. To overcome these limitations, a 9-site National Cancer Institute Patient Navigation Research Program (PNRP) was initiated. METHODS: The PNRP is charged with designing, implementing, and evaluating a generalizable patient navigation program targeting vulnerable populations. Through a formal committee structure, the PNRP has developed a definition of patient navigation and metrics to assess the process and outcomes of patient navigation in diverse settings, compared with concurrent continuous control groups. RESULTS: The PNRP defines patient navigation as support and guidance offered to vulnerable persons with abnormal cancer screening or a cancer diagnosis, with the goal of overcoming barriers to timely, quality care. Primary outcomes of the PNRP are 1) time to diagnostic resolution; 2) time to initiation of cancer treatment; 3) patient satisfaction with care; and 4) cost effectiveness, for breast, cervical, colon/rectum, and/or prostate cancer. CONCLUSIONS: The metrics to assess the processes and outcomes of patient navigation have been developed for the NCI-sponsored PNRP. If the metrics are found to be valid and reliable, they may prove useful to other investigators.
BACKGROUND:Patient, provider, and systems barriers contribute to delays in cancer care, a lower quality of care, and poorer outcomes in vulnerable populations, including low-income, underinsured, and racial/ethnic minority populations. Patient navigation is emerging as an intervention to address this problem, but navigation requires a clear definition and a rigorous testing of its effectiveness. Pilot programs have provided some evidence of benefit, but have been limited by evaluation of single-site interventions and varying definitions of navigation. To overcome these limitations, a 9-site National Cancer Institute Patient Navigation Research Program (PNRP) was initiated. METHODS: The PNRP is charged with designing, implementing, and evaluating a generalizable patient navigation program targeting vulnerable populations. Through a formal committee structure, the PNRP has developed a definition of patient navigation and metrics to assess the process and outcomes of patient navigation in diverse settings, compared with concurrent continuous control groups. RESULTS: The PNRP defines patient navigation as support and guidance offered to vulnerable persons with abnormal cancer screening or a cancer diagnosis, with the goal of overcoming barriers to timely, quality care. Primary outcomes of the PNRP are 1) time to diagnostic resolution; 2) time to initiation of cancer treatment; 3) patient satisfaction with care; and 4) cost effectiveness, for breast, cervical, colon/rectum, and/or prostate cancer. CONCLUSIONS: The metrics to assess the processes and outcomes of patient navigation have been developed for the NCI-sponsored PNRP. If the metrics are found to be valid and reliable, they may prove useful to other investigators.
Authors: Susan L Norris; Phyllis J Nichols; Carl J Caspersen; Russell E Glasgow; Michael M Engelgau; Leonard Jack; George Isham; Susan R Snyder; Vilma G Carande-Kulis; Sanford Garfield; Peter Briss; David McCulloch Journal: Am J Prev Med Date: 2002-05 Impact factor: 5.043
Authors: A L Abner; L Collins; G Peiro; A Recht; S Come; L N Shulman; B Silver; A Nixon; J R Harris; S J Schnitt; J L Connolly Journal: Cancer Date: 1998-12-15 Impact factor: 6.860
Authors: Hannah K Weir; Michael J Thun; Benjamin F Hankey; Lynn A G Ries; Holly L Howe; Phyllis A Wingo; Ahmedin Jemal; Elizabeth Ward; Robert N Anderson; Brenda K Edwards Journal: J Natl Cancer Inst Date: 2003-09-03 Impact factor: 13.506
Authors: Sankar D Navaneethan; Stacey E Jolly; Jesse D Schold; Susana Arrigain; Georges Nakhoul; Victoria Konig; Jennifer Hyland; Yvette K Burrucker; Priscilla Davis Dann; Barbara H Tucky; John Sharp; Joseph V Nally Journal: Clin J Am Soc Nephrol Date: 2017-08-04 Impact factor: 8.237
Authors: Pascal Jean-Pierre; Kevin Fiscella; Karen M Freund; Jack Clark; Julie Darnell; Alan Holden; Douglas Post; Steven R Patierno; Paul C Winters Journal: Cancer Date: 2010-10-04 Impact factor: 6.860
Authors: Karen M Freund; Alexis P Isabelle; Amresh D Hanchate; Richard L Kalish; Alok Kapoor; Sharon Bak; Rebecca G Mishuris; Swati M Shroff; Tracy A Battaglia Journal: J Health Care Poor Underserved Date: 2014-02
Authors: Ambili Ramachandran; Frederick R Snyder; Mira L Katz; Julie S Darnell; Donald J Dudley; Steven R Patierno; Mechelle R Sanders; Patricia A Valverde; Melissa A Simon; Victoria Warren-Mears; Tracy A Battaglia Journal: Cancer Date: 2015-08-19 Impact factor: 6.860
Authors: Richard G Roetzheim; Ji-Hyun Lee; Ercilia R Calcano; Cathy D Meade; William J Fulp; Kristen J Wells Journal: J Health Care Poor Underserved Date: 2012-08
Authors: Mira L Katz; Gregory S Young; Paul L Reiter; Tracy A Battaglia; Kristen J Wells; Mechelle Sanders; Melissa Simon; Donald J Dudley; Steven R Patierno; Electra D Paskett Journal: Womens Health Issues Date: 2014 Jan-Feb
Authors: Jennifer K Carroll; Sharon G Humiston; Sean C Meldrum; Charcy M Salamone; Pascal Jean-Pierre; Ronald M Epstein; Kevin Fiscella Journal: Patient Educ Couns Date: 2009-12-16